• |
Major industrial unit, manufacturing gum that conforms to international standards and exporting the produce across the globe |
• |
Caters to a diverse range of industries |
|
| |
Case Outline |
|
• |
Process boilers and hot air generators |
• |
The facility used Imported Coal / Lignite (consumption 30 tons/day), and conducted a 90 day trial for use of Pellexo |
|
| |
Outcomes Achieved |
|
• |
Reduction in carbon emission & local pollutants |
• |
CO2 emission to the tune of 21,000 tonnes / annum |
• |
SOx Reduction: to the tune of 60-110 tonnes p.a., reduction in other local pollutants: |
• |
Actual fuel consumption reduced by 5 to 8 % |
• |
Reduction in fuel handling and processing cost approx. |
|
| |
Other Benefits |
|
• |
Less ash and un-burnt fuel particles noticed during the trial |
• |
Low dust near the utility area |
• |
Constant bed temperature and steam temperature |
|
| |
| |
Sector: Pharmaceuticals |
| |
Company |
|
• |
One of India’s leading pharmaceutical companies |
• |
Presence across 76 countries |
• |
Manufactures high-end injectables and New Drug Delivery Systems for critically ill patients |
• |
State-of-the-art 80 acre green manufacturing campus holding all key international |
• |
Regulatory approvals including USFDA, MHRA UK, TGA Australia and more |
| |
|
|
| |
Case Outline |
|
• |
The company has a 2 MW Co-generation facility, approved by UNFCCC as a CDM project |
• |
Facility earlier run on Coal / Lignite based energy generation, now converted to biomass based energy generation |
|
| |
Outcomes Achieved |
|
• |
Reduction in Carbon Emission & Local Pollutants |
• |
Reduced 44,000 tonnes of CO2e emission per annum |
• |
SOx Reduction: upto 120-200 tonnes p.a., and other local pollutants: |
• |
Reduced fuel consumption approx. 10,000 tonnes p.a. |
• |
Reduction in fuel handling and processing cost approx. |
|
| |
